To download and read the full report please enter your details below.
In this report, we reveal industry predictions for the rare disease landscape in 2034 and explore key approaches that show great promise, including gene therapies, artificial intelligence, whole-genome screening and personalised treatment, before assessing what the top priorities should be over the next decade to improve patient care.